Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 59 entries
Sorted by: Best Match Show Resources per page
Characteristics of hepatitis B infection in a sample of omani patients.

Sultan Qaboos University medical journal

Al-Naamani K, Al-Maqbali A, Al-Sinani S.
PMID: 23984022
Sultan Qaboos Univ Med J. 2013 Aug;13(3):380-5. doi: 10.12816/0003259. Epub 2013 Jun 25.

OBJECTIVES: This study aimed to describe the demographic and virological characteristics of chronic hepatitis B virus (HBV) infection in a sample of Omani patients, and indirectly assess the efficacy of hepatitis B vaccination programmes and catch-up strategies.METHODS: A retrospective...

Cite
Al-Naamani K, Al-Maqbali A, Al-Sinani S. Characteristics of hepatitis B infection in a sample of omani patients. Sultan Qaboos Univ Med J. 2013;13(3):380-5doi: 10.12816/0003259.
Al-Naamani, K., Al-Maqbali, A., & Al-Sinani, S. (2013). Characteristics of hepatitis B infection in a sample of omani patients. Sultan Qaboos University medical journal, 13(3), 380-5. https://doi.org/10.12816/0003259
Al-Naamani, Khalid, et al. "Characteristics of hepatitis B infection in a sample of omani patients." Sultan Qaboos University medical journal vol. 13,3 (2013): 380-5. doi: https://doi.org/10.12816/0003259
Al-Naamani K, Al-Maqbali A, Al-Sinani S. Characteristics of hepatitis B infection in a sample of omani patients. Sultan Qaboos Univ Med J. 2013 Aug;13(3):380-5. doi: 10.12816/0003259. Epub 2013 Jun 25. PMID: 23984022; PMCID: PMC3749021.
Copy Download .nbib Format: NLM
Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute lymphoblastic leukemia.

Revista brasileira de hematologia e hemoterapia

Viana SS, Araujo GS, Faro GB, da Cruz-Silva LL, Araújo-Melo CA, Cipolotti R.
PMID: 23049440
Rev Bras Hematol Hemoter. 2012;34(4):275-9. doi: 10.5581/1516-8484.20120071.

OBJECTIVE: To evaluate viral vaccine antibody levels in children with acute lymphoblastic leukemia after chemotherapy and after vaccine booster doses.METHODS: Antibody levels against hepatitis B, rubella, measles and mumps vaccine antigens were evaluated in 33 children after completing chemotherapy...

Cite
Viana SS, Araujo GS, Faro GB, et al. Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute lymphoblastic leukemia. Rev Bras Hematol Hemoter. 2012;34(4):275-9doi: 10.5581/1516-8484.20120071.
Viana, S. S., Araujo, G. S., Faro, G. B., da Cruz-Silva, L. L., Araújo-Melo, C. A., & Cipolotti, R. (2012). Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute lymphoblastic leukemia. Revista brasileira de hematologia e hemoterapia, 34(4), 275-9. https://doi.org/10.5581/1516-8484.20120071
Viana, Simone Santana, et al. "Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute lymphoblastic leukemia." Revista brasileira de hematologia e hemoterapia vol. 34,4 (2012): 275-9. doi: https://doi.org/10.5581/1516-8484.20120071
Viana SS, Araujo GS, Faro GB, da Cruz-Silva LL, Araújo-Melo CA, Cipolotti R. Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute lymphoblastic leukemia. Rev Bras Hematol Hemoter. 2012;34(4):275-9. doi: 10.5581/1516-8484.20120071. PMID: 23049440; PMCID: PMC3460395.
Copy Download .nbib Format: NLM
Rate of acquired immunity in dental students after hepatitis B vaccination.

Dental research journal

Lasemi E, Haddadpour N, Navi F, Rakhshan A, Rakhshan V.
PMID: 22013475
Dent Res J (Isfahan). 2011;8(3):128-31.

BACKGROUND: Triple-course vaccination against hepatitis B might sometimes fail to increase antibody titers or maintain it at sufficient levels. The aim of this study was to evaluate the rate of seroprotection in dental students after receiving recombinant hepatitis B...

Cite
Lasemi E, Haddadpour N, Navi F, et al. Rate of acquired immunity in dental students after hepatitis B vaccination. Dent Res J (Isfahan). 2011;8(3):128-31
Lasemi, E., Haddadpour, N., Navi, F., Rakhshan, A., & Rakhshan, V. (2011). Rate of acquired immunity in dental students after hepatitis B vaccination. Dental research journal, 8(3), 128-31.
Lasemi, Eshagh, et al. "Rate of acquired immunity in dental students after hepatitis B vaccination." Dental research journal vol. 8,3 (2011): 128-31.
Lasemi E, Haddadpour N, Navi F, Rakhshan A, Rakhshan V. Rate of acquired immunity in dental students after hepatitis B vaccination. Dent Res J (Isfahan). 2011;8(3):128-31. PMID: 22013475; PMCID: PMC3177387.
Copy Download .nbib Format: NLM
Evaluation of thimerosal removal on immunogenicity of aluminum salts adjuvanted recombinant hepatitis B vaccine.

Iranian journal of pharmaceutical research : IJPR

Mahboubi A, Fazeli MR, Samadi N, Dinarvand R, Azadi S.
PMID: 25317183
Iran J Pharm Res. 2012;11(1):39-46.

Thimerosal, which is approximately 50% mercury by weight is a preservative widely used in vaccines since the 1930's. It meets the requirements for a preservative as set forth by Pharmacopeia challenge test and has been shown to be effective...

Cite
Mahboubi A, Fazeli MR, Samadi N, et al. Evaluation of thimerosal removal on immunogenicity of aluminum salts adjuvanted recombinant hepatitis B vaccine. Iran J Pharm Res. 2012;11(1):39-46
Mahboubi, A., Fazeli, M. R., Samadi, N., Dinarvand, R., & Azadi, S. (2012). Evaluation of thimerosal removal on immunogenicity of aluminum salts adjuvanted recombinant hepatitis B vaccine. Iranian journal of pharmaceutical research : IJPR, 11(1), 39-46.
Mahboubi, Arash, et al. "Evaluation of thimerosal removal on immunogenicity of aluminum salts adjuvanted recombinant hepatitis B vaccine." Iranian journal of pharmaceutical research : IJPR vol. 11,1 (2012): 39-46.
Mahboubi A, Fazeli MR, Samadi N, Dinarvand R, Azadi S. Evaluation of thimerosal removal on immunogenicity of aluminum salts adjuvanted recombinant hepatitis B vaccine. Iran J Pharm Res. 2012;11(1):39-46. PMID: 25317183; PMCID: PMC3876573.
Copy Download .nbib Format: NLM
Safety and efficacy of hepatitis B vaccination in cirrhosis of liver.

Advances in virology

Roni DA, Pathapati RM, Kumar AS, Nihal L, Sridhar K, Tumkur Rajashekar S.
PMID: 23840211
Adv Virol. 2013;2013:196704. doi: 10.1155/2013/196704. Epub 2013 Jun 06.

Introduction. Patients with chronic liver disease (CLD) are more likely to have severe morbidity and fatality rate due to superimposed acute or chronic hepatitis B (HBV) infection. The literature has shown that hepatitis B vaccines are safe and effective...

Cite
Roni DA, Pathapati RM, Kumar AS, et al. Safety and efficacy of hepatitis B vaccination in cirrhosis of liver. Adv Virol. 2013;2013:196704doi: 10.1155/2013/196704.
Roni, D. A., Pathapati, R. M., Kumar, A. S., Nihal, L., Sridhar, K., & Tumkur Rajashekar, S. (2013). Safety and efficacy of hepatitis B vaccination in cirrhosis of liver. Advances in virology, 2013196704. https://doi.org/10.1155/2013/196704
Roni, D Ajith, et al. "Safety and efficacy of hepatitis B vaccination in cirrhosis of liver." Advances in virology vol. 2013 (2013): 196704. doi: https://doi.org/10.1155/2013/196704
Roni DA, Pathapati RM, Kumar AS, Nihal L, Sridhar K, Tumkur Rajashekar S. Safety and efficacy of hepatitis B vaccination in cirrhosis of liver. Adv Virol. 2013;2013:196704. doi: 10.1155/2013/196704. Epub 2013 Jun 06. PMID: 23840211; PMCID: PMC3690205.
Copy Download .nbib Format: NLM
Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis.

Hepatitis monthly

Rezaee R, Poorebrahim M, Najafi S, Sadeghi S, Pourdast A, Alavian SM, Alavian SE, Poortahmasebi V.
PMID: 27642350
Hepat Mon. 2016 Jun 28;16(7):e39097. doi: 10.5812/hepatmon.39097. eCollection 2016 Jul.

BACKGROUND: Vaccine-escaped hepatitis B virus (HBV) mutations occur within the "a" determinant area, which is located in the major hydrophilic region (MHR) of the hepatitis B surface antigen (HBsAg) protein. It is now well established that the common G145R...

Cite
Rezaee R, Poorebrahim M, Najafi S, et al. Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis. Hepat Mon. 2016;16(7):e39097doi: 10.5812/hepatmon.39097.
Rezaee, R., Poorebrahim, M., Najafi, S., Sadeghi, S., Pourdast, A., Alavian, S. M., Alavian, S. E., & Poortahmasebi, V. (2016). Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis. Hepatitis monthly, 16(7), e39097. https://doi.org/10.5812/hepatmon.39097
Rezaee, Reza, et al. "Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis." Hepatitis monthly vol. 16,7 (2016): e39097. doi: https://doi.org/10.5812/hepatmon.39097
Rezaee R, Poorebrahim M, Najafi S, Sadeghi S, Pourdast A, Alavian SM, Alavian SE, Poortahmasebi V. Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis. Hepat Mon. 2016 Jun 28;16(7):e39097. doi: 10.5812/hepatmon.39097. eCollection 2016 Jul. PMID: 27642350; PMCID: PMC5018363.
Copy Download .nbib Format: NLM
Safety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studies.

Journal of pharmaceutical health care and sciences

Ogawa Y, Takei H, Ogawa R, Mihara K.
PMID: 28702209
J Pharm Health Care Sci. 2017 Jul 11;3:18. doi: 10.1186/s40780-017-0087-6. eCollection 2017.

BACKGROUND: Human papillomavirus (HPV) vaccines have been shown to be effective for the eradication of HPV and prevention of cervical cancer. However, the number of women who receive HPV vaccinations has decreased over the last several years in Japan,...

Cite
Ogawa Y, Takei H, Ogawa R, et al. Safety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studies. J Pharm Health Care Sci. 2017;3:18doi: 10.1186/s40780-017-0087-6.
Ogawa, Y., Takei, H., Ogawa, R., & Mihara, K. (2017). Safety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studies. Journal of pharmaceutical health care and sciences, 318. https://doi.org/10.1186/s40780-017-0087-6
Ogawa, Yukari, et al. "Safety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studies." Journal of pharmaceutical health care and sciences vol. 3 (2017): 18. doi: https://doi.org/10.1186/s40780-017-0087-6
Ogawa Y, Takei H, Ogawa R, Mihara K. Safety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studies. J Pharm Health Care Sci. 2017 Jul 11;3:18. doi: 10.1186/s40780-017-0087-6. eCollection 2017. PMID: 28702209; PMCID: PMC5504559.
Copy Download .nbib Format: NLM
Thimerosal-Preserved Hepatitis B Vaccine and Hyperkinetic Syndrome of Childhood.

Brain sciences

Geier DA, Kern JK, Hooker BS, Sykes LK, Geier MR.
PMID: 26999226
Brain Sci. 2016 Mar 15;6(1). doi: 10.3390/brainsci6010009.

(1) BACKGROUND: Hyperkinetic syndrome of childhood (HKSoC) is an International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) category in which the majority of the children are also diagnosed under the Diagnostic and Statistical Manual of Mental Disorders, 4th...

Cite
Geier DA, Kern JK, Hooker BS, et al. Thimerosal-Preserved Hepatitis B Vaccine and Hyperkinetic Syndrome of Childhood. Brain Sci. 2016;6(1)doi: 10.3390/brainsci6010009.
Geier, D. A., Kern, J. K., Hooker, B. S., Sykes, L. K., & Geier, M. R. (2016). Thimerosal-Preserved Hepatitis B Vaccine and Hyperkinetic Syndrome of Childhood. Brain sciences, 6(1), . https://doi.org/10.3390/brainsci6010009
Geier, David A, et al. "Thimerosal-Preserved Hepatitis B Vaccine and Hyperkinetic Syndrome of Childhood." Brain sciences vol. 6,1 (2016). doi: https://doi.org/10.3390/brainsci6010009
Geier DA, Kern JK, Hooker BS, Sykes LK, Geier MR. Thimerosal-Preserved Hepatitis B Vaccine and Hyperkinetic Syndrome of Childhood. Brain Sci. 2016 Mar 15;6(1). doi: 10.3390/brainsci6010009. PMID: 26999226; PMCID: PMC4810179.
Copy Download .nbib Format: NLM
Persistence of Anti-HBs Among Palestinian Medical Students After 18 - 22 Years of Vaccination: A Cross-Sectional Study.

Hepatitis monthly

Dumaidi K, Al-Jawabreh A.
PMID: 26834785
Hepat Mon. 2015 Nov 07;15(11):e29325. doi: 10.5812/hepatmon.29325. eCollection 2015 Nov.

BACKGROUND: Hepatitis B infection is a global public health problem affecting various sectors in the society. Vaccination is the first line measure to prevent the disease.OBJECTIVES: To assess the persistence of anti-HBs marker among medical students after 18 -...

Cite
Dumaidi K, Al-Jawabreh A. Persistence of Anti-HBs Among Palestinian Medical Students After 18 - 22 Years of Vaccination: A Cross-Sectional Study. Hepat Mon. 2015;15(11):e29325doi: 10.5812/hepatmon.29325.
Dumaidi, K., & Al-Jawabreh, A. (2015). Persistence of Anti-HBs Among Palestinian Medical Students After 18 - 22 Years of Vaccination: A Cross-Sectional Study. Hepatitis monthly, 15(11), e29325. https://doi.org/10.5812/hepatmon.29325
Dumaidi, Kamal, and Al-Jawabreh, Amer. "Persistence of Anti-HBs Among Palestinian Medical Students After 18 - 22 Years of Vaccination: A Cross-Sectional Study." Hepatitis monthly vol. 15,11 (2015): e29325. doi: https://doi.org/10.5812/hepatmon.29325
Dumaidi K, Al-Jawabreh A. Persistence of Anti-HBs Among Palestinian Medical Students After 18 - 22 Years of Vaccination: A Cross-Sectional Study. Hepat Mon. 2015 Nov 07;15(11):e29325. doi: 10.5812/hepatmon.29325. eCollection 2015 Nov. PMID: 26834785; PMCID: PMC4717190.
Copy Download .nbib Format: NLM
Combination vaccines.

Journal of global infectious diseases

Skibinski DA, Baudner BC, Singh M, O'Hagan DT.
PMID: 21572611
J Glob Infect Dis. 2011 Jan;3(1):63-72. doi: 10.4103/0974-777X.77298.

The combination of diphtheria, tetanus, and pertussis vaccines into a single product has been central to the protection of the pediatric population over the past 50 years. The addition of inactivated polio, Haemophilus influenzae, and hepatitis B vaccines into...

Cite
Skibinski DA, Baudner BC, Singh M, et al. Combination vaccines. J Glob Infect Dis. 2011;3(1):63-72doi: 10.4103/0974-777X.77298.
Skibinski, D. A., Baudner, B. C., Singh, M., & O'Hagan, D. T. (2011). Combination vaccines. Journal of global infectious diseases, 3(1), 63-72. https://doi.org/10.4103/0974-777X.77298
Skibinski, David Ag, et al. "Combination vaccines." Journal of global infectious diseases vol. 3,1 (2011): 63-72. doi: https://doi.org/10.4103/0974-777X.77298
Skibinski DA, Baudner BC, Singh M, O'Hagan DT. Combination vaccines. J Glob Infect Dis. 2011 Jan;3(1):63-72. doi: 10.4103/0974-777X.77298. PMID: 21572611; PMCID: PMC3068581.
Copy Download .nbib Format: NLM
A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States.

Translational neurodegeneration

Geier DA, Hooker BS, Kern JK, King PG, Sykes LK, Geier MR.
PMID: 24354891
Transl Neurodegener. 2013 Dec 19;2(1):25. doi: 10.1186/2047-9158-2-25.

BACKGROUND: Autism spectrum disorder (ASD) is defined by standardized criteria of qualitative impairments in social interaction, qualitative impairments in communication, and restricted and stereotyped patterns of behavior, interests, and activities. A significant number of children diagnosed with ASD suffer...

Cite
Geier DA, Hooker BS, Kern JK, et al. A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States. Transl Neurodegener. 2013;2(1):25doi: 10.1186/2047-9158-2-25.
Geier, D. A., Hooker, B. S., Kern, J. K., King, P. G., Sykes, L. K., & Geier, M. R. (2013). A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States. Translational neurodegeneration, 2(1), 25. https://doi.org/10.1186/2047-9158-2-25
Geier, David A, et al. "A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States." Translational neurodegeneration vol. 2,1 (2013): 25. doi: https://doi.org/10.1186/2047-9158-2-25
Geier DA, Hooker BS, Kern JK, King PG, Sykes LK, Geier MR. A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States. Transl Neurodegener. 2013 Dec 19;2(1):25. doi: 10.1186/2047-9158-2-25. PMID: 24354891; PMCID: PMC3878266.
Copy Download .nbib Format: NLM
Do we have to shift three doses of hepatitis B vaccine instead of four doses in chronic renal failure: think before action.

Hepatitis monthly

Afsar B.
PMID: 23675386
Hepat Mon. 2013 Mar 13;13(3):e8037. doi: 10.5812/hepatmon.8037. Print 2013 Mar.

No abstract available.

Cite
Afsar B. Do we have to shift three doses of hepatitis B vaccine instead of four doses in chronic renal failure: think before action. Hepat Mon. 2013;13(3):e8037doi: 10.5812/hepatmon.8037.
Afsar, B. (2013). Do we have to shift three doses of hepatitis B vaccine instead of four doses in chronic renal failure: think before action. Hepatitis monthly, 13(3), e8037. https://doi.org/10.5812/hepatmon.8037
Afsar, Baris. "Do we have to shift three doses of hepatitis B vaccine instead of four doses in chronic renal failure: think before action." Hepatitis monthly vol. 13,3 (2013): e8037. doi: https://doi.org/10.5812/hepatmon.8037
Afsar B. Do we have to shift three doses of hepatitis B vaccine instead of four doses in chronic renal failure: think before action. Hepat Mon. 2013 Mar 13;13(3):e8037. doi: 10.5812/hepatmon.8037. Print 2013 Mar. PMID: 23675386; PMCID: PMC3651844.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 59 entries